IN BRIEF: Faron Pharmaceuticals appoints new chief business officer

Related news

Faron Pharmaceuticals Ltd - Turku, Finland-based developer of cancer immunotherapies - Appoints Ralph Hughes as chief business officer, effective from next Wednesday. Notes Hughes’ prior experience as senior vice president at PharmaVentures, and his extensive experience in commercial due diligence, market access and the business development process. Adds that he will be part of the management team and the business development team. ‘We are delighted to have such an experienced pharmaceutical market access and strategic commercial development expert to join us as the new CBO’, says Chief Executive Juho Jalkanen. ‘Ralph’s proven track record in biopharma leadership and his experience align perfectly with our corporate development efforts and strategic growth initiatives.’

Current stock price: 227.00 pence, up 2.7% on Wednesday afternoon in London

12-month change: up 15%

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Directors

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.